To Achieve Blood Pressure Control With Retained Quality of Life

Hypertension Clinical Trial

Official title:

Possibilities for Patients With Elevated Blood Pressure to Achieve Blood Pressure Control Without Affecting Quality of Life (the PEQ Study)

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT02682095
• Other study ID #: The PEQ-study
• Status: Terminated
• Start date: April 2016
• Est. completion date: May 31, 2019

Study information

• Verified date: March 2021
• Source: Lund University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of the study is to get an understanding about what problems patients with hypertension are facing, how they manage these challenges, how they feel and what requirements they believe are important to have in their treatment. These factors will later act as a foundation and incentive for designing an intervention that may result in more patients achieving blood pressure control with maintained quality of life.

Description:

This is a Swedish observational mixed-methods study to get an understanding about what problems patients with hypertension are facing. The information will act as a foundation for designing an intervention/interventions that may result in more patients achieving blood pressure control with maintained quality of life. Patients, who have well/not well controlled blood pressure, are to fill in questionnaires about their view on ability to perform self-care and their perceived quality of life. Individual interviews will also be made about for what reasons they do or do not change lifestyle as well as take their drugs to treat their hypertension. In focus group interviews the patients are to be asked about what they want and expect in the encounter with health care personnel, what other things outside the health care area would be helpful for the patient and how age, gender, cultural and psychosocial aspects affect the ability to achieve blood pressure control. The developed future interventions will be evaluated in clinical practice.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 12
• Est. completion date: May 31, 2019
• Est. primary completion date: May 31, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years and older

Eligibility

Inclusion Criteria:

• diagnosed with hypertension since 9 months

• being able to read and speak Swedish

Exclusion Criteria:

-

Related Conditions & MeSH terms

• Hypertension
• Patient Compliance

Locations

Country	Name	City	State
Sweden	Department of Health Sciences	Lund

Sponsors (1)

Lead Sponsor	Collaborator
Eva Drevenhorn

Country where clinical trial is conducted

Sweden, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Self-care agency	Exercise of Self Care Agency (ESCA) instrument	through study completion, an average of 6 months
Primary	Quality of life: SF-36	Short Form Health Survey, 36 items	through study completion, an average of 6 months
Primary	Individual interviews	Semistructured interviews	through study completion, an average of 3 months
Primary	Focus-group interviews	Discussions in focus-groups	through study completion, an average of 1 year